A detailed history of Stifel Financial Corp transactions in Organon & Co. stock. As of the latest transaction made, Stifel Financial Corp holds 207,737 shares of OGN stock, worth $3.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
207,737
Previous 235,402 11.75%
Holding current value
$3.97 Million
Previous $4.43 Million 2.82%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $482,754 - $607,523
-27,665 Reduced 11.75%
207,737 $4.3 Million
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $172,759 - $235,695
-12,537 Reduced 5.06%
235,402 $4.43 Million
Q4 2023

Feb 12, 2024

SELL
$10.95 - $17.32 $7.72 Million - $12.2 Million
-705,110 Reduced 73.98%
247,939 $3.58 Million
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $481,657 - $690,114
29,033 Added 3.14%
953,049 $16.5 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $7,476 - $9,556
-388 Reduced 0.04%
924,016 $19.2 Million
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $1.84 Million - $2.75 Million
85,718 Added 10.22%
924,404 $21.7 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $3.11 Million - $3.82 Million
-133,571 Reduced 13.74%
838,686 $23.4 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $836,620 - $1.22 Million
-35,753 Reduced 3.55%
972,257 $22.8 Million
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $261,923 - $321,819
8,273 Added 0.83%
1,008,010 $34 Million
Q1 2022

May 13, 2022

BUY
$30.45 - $39.36 $2.32 Million - $2.99 Million
76,087 Added 8.24%
999,737 $34.9 Million
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $15.8 Million - $20.4 Million
549,508 Added 146.87%
923,650 $28.1 Million
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $5.16 Million - $6.43 Million
-180,323 Reduced 32.52%
374,142 $12.3 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $15.8 Million - $21.1 Million
554,465 New
554,465 $16.8 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.87B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.